CEO: Sophie Baratte

Advent Contact: Raj Parekh

Micro insulin pump for mobile diabetes management

The Cellnovo system is the world’s first mobile diabetes management system, including an insulin patch pump, activity monitor, cellular-enabled wireless touchscreen handset with integrated blood glucose meter and automatic connectivity. The system allows optimal management of insulin injections whilst ensuring extensive freedom of movement for Type 1 diabetes patients. The system has CE mark, and is on the market in the United Kingdom and several European countries.

Advent invested in the Series A in 2008. Cellnovo listed on Euronext in July 2015 (EPA:CLNV).